Home/Filings/4/0001415889-24-017531
4//SEC Filing

Tsai Philip 4

Accession 0001415889-24-017531

CIK 0001472012other

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 9:08 PM ET

Size

5.5 KB

Accession

0001415889-24-017531

Insider Transaction Report

Form 4
Period: 2024-06-17
Tsai Philip
Chief Technology Officer
Transactions
  • Award

    Stock option (right to buy)

    2024-06-17+250,000250,000 total
    Exercise: $13.15Exp: 2034-06-16Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1
  • filerCIK 0002026600

Filing Metadata

Form type
4
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 9:08 PM ET
Size
5.5 KB